Vitrakvi 71777-0391-01
Generic: Larotrectinib
- Manufacturer
- Loxo Oncology, Inc.
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- November 26, 2018
- Listing Expires
- December 31, 2026
- Application
- NDA210861
Need to source Vitrakvi? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Larotrectinib | 100 mg/1 |
Drug Class
Kinase Inhibitor [EPC]Kinase Inhibitor [EPC]Tropomyosin Receptor Kinases Inhibitors [MoA]
Selected Package
71777-0391-01Selected60 CAPSULE in 1 BOTTLE (71777-391-01)